Current investments - Metenova
Metenova is a MedTech company delivering products and solutions for the pharmaceutical and biotech production of aseptic and sterile products. The customer base is mainly leading pharmaceutical companies and biological drug producting companies.
The portfolio consists of mixers adapted to different types of applications based on the company’s patented technologies.
Metenova operates globally with sales in more than 30 countries, mainly through a distributor network with headquarters in Mölndal, in the south of Sweden, and a subsidiary in New Jersey, USA.
For further information, please contact
Louise Nilsson is Partner and CEO. In addition to leading and developing Priveq, she is responsible for sourcing new investment opportunities, in which Priveq will contribute with growth and value creation as well as implement growth strategies in cooperation with other owners, the board and management.
Since Louise joined Priveq in 1998, she has, among others, been responsible for the ownership in Carmel Pharma, Hemtex, Swedish Orphan International and Vårdapoteket. She is currently a Director of the Boards in 21 Grams, ByggPartner i Dalarna, CSAM Health, Metenova and Ports Group.
Prior to Priveq, Louise worked as chartered accountant for ÖhrlingsCoopers & Lybrand (current PwC) for nine years, with responsibility for small and medium-sized owner-led companies.
Louise holds a B.Sc. in Business Administration from Luleå University.